Molecular Monitoring and Treatment of Chronic Myeloid Leukemia (CML)
Received Date: May 09, 2012 / Accepted Date: Jun 14, 2012 / Published Date: Jun 17, 2012
Keywords: CML; Targeted therapy; Tyrosine kinase inhibitors; Drug resistance; Molecular monitoring
Citation: Singh Z, Medlin S, Usmani SZ (2012) Molecular Monitoring and Treatment of Chronic Myeloid Leukemia (CML). J Clin Exp Pathol 2:113. Doi: 10.4172/2161-0681.1000113
Copyright: © 2012 Singh Z, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.